136 related articles for article (PubMed ID: 35583632)
21. Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.
He C; Liu B; Wang HY; Wu L; Zhao G; Huang C; Liu Y; Shan B; Liu L
BMC Cancer; 2022 Oct; 22(1):1100. PubMed ID: 36303126
[TBL] [Abstract][Full Text] [Related]
22. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
[TBL] [Abstract][Full Text] [Related]
23. Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC.
Gong L; Song J; Lin X; Wei F; Zhang C; Wang Z; Zhu J; Wu S; Chen Y; Liang J; Fu X; Lu J; Zhou C; Song L
J Pathol; 2016 Oct; 240(2):184-96. PubMed ID: 27391422
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) - splicing factor axis.
Mole S; Faizo AAA; Hernandez-Lopez H; Griffiths M; Stevenson A; Roberts S; Graham SV
J Gen Virol; 2020 May; 101(5):523-532. PubMed ID: 32182205
[TBL] [Abstract][Full Text] [Related]
25. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Kurimchak AM; Kumar V; Herrera-Montávez C; Johnson KJ; Srivastava N; Davarajan K; Peri S; Cai KQ; Mantia-Smaldone GM; Duncan JS
Mol Cell Proteomics; 2020 Dec; 19(12):2068-2090. PubMed ID: 32994315
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression.
Chandra A; Ananda H; Singh N; Qamar I
Aging (Albany NY); 2020 Dec; 13(1):163-180. PubMed ID: 33291073
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro.
Odunsi K; Mhawech-Fauceglia P; Andrews C; Beck A; Amuwo O; Lele S; Black JD; Huang RY
PLoS One; 2012; 7(12):e51030. PubMed ID: 23236423
[TBL] [Abstract][Full Text] [Related]
28. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.
Chang Y; Wu Q; Tian T; Li L; Guo X; Feng Z; Zhou J; Zhang L; Zhou S; Feng G; Han F; Yang J; Huang F
Tumour Biol; 2015 Aug; 36(8):6083-93. PubMed ID: 25833691
[TBL] [Abstract][Full Text] [Related]
29. Role of Serine arginine protein kinase 1 and Minichromosome maintenance protein 2 in predicting epithelial ovarian cancer response to treatment and prognosis.
Elkholy E; Abdou AG; Alhanafy AM; Hashem T; Hassan R; Shehata M
Indian J Cancer; 2024 Jan; ():. PubMed ID: 38216547
[TBL] [Abstract][Full Text] [Related]
30. SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer.
Huang JQ; Li HF; Zhu J; Song JW; Zhang XB; Gong P; Liu QY; Zhou CH; Wang L; Gong LY
J Transl Med; 2021 Jun; 19(1):280. PubMed ID: 34193174
[TBL] [Abstract][Full Text] [Related]
31. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.
Wang P; Zhou Z; Hu A; Ponte de Albuquerque C; Zhou Y; Hong L; Sierecki E; Ajiro M; Kruhlak M; Harris C; Guan KL; Zheng ZM; Newton AC; Sun P; Zhou H; Fu XD
Mol Cell; 2014 May; 54(3):378-91. PubMed ID: 24703948
[TBL] [Abstract][Full Text] [Related]
32. Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention.
Patel M; Sachidanandan M; Adnan M
Mol Biol Rep; 2019 Feb; 46(1):1487-1497. PubMed ID: 30535769
[TBL] [Abstract][Full Text] [Related]
33. SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells.
Wang C; Zhou Z; Subhramanyam CS; Cao Q; Heng ZSL; Liu W; Fu X; Hu Q
Commun Biol; 2020 May; 3(1):268. PubMed ID: 32461560
[TBL] [Abstract][Full Text] [Related]
34. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
35. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.
Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301
[TBL] [Abstract][Full Text] [Related]
36. Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate.
Aubol BE; Jamros MA; McGlone ML; Adams JA
Biochemistry; 2013 Oct; 52(43):7595-605. PubMed ID: 24074032
[TBL] [Abstract][Full Text] [Related]
37. Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions.
Xu X; Wei Y; Wang S; Luo M; Zeng H
Oncotarget; 2017 Sep; 8(37):61944-61957. PubMed ID: 28977917
[TBL] [Abstract][Full Text] [Related]
38. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases.
Oltean S; Gammons M; Hulse R; Hamdollah-Zadeh M; Mavrou A; Donaldson L; Salmon AH; Harper SJ; Ladomery MR; Bates DO
Biochem Soc Trans; 2012 Aug; 40(4):831-5. PubMed ID: 22817743
[TBL] [Abstract][Full Text] [Related]
39. Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1.
Ma CT; Hagopian JC; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2009 Jul; 390(4):618-34. PubMed ID: 19477182
[TBL] [Abstract][Full Text] [Related]
40. Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.
Li XH; Song JW; Liu JL; Wu S; Wang LS; Gong LY; Lin X
Med Oncol; 2014 Aug; 31(8):83. PubMed ID: 24961466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]